DICE

DICE Therapeutics (DICE)

DICE Therapeutics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DICE

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
08/21/2023	8:00AM	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:DICE	DICE Therapeutics Inc
08/11/2023	12:15AM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	4:36PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	4:31PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	4:26PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	4:23PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	4:21PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	4:19PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:47AM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:45AM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:42AM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:38AM	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:32AM	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:26AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:20AM	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
08/09/2023	9:02AM	PR Newswire (US)	Lilly Completes Acquisition of DICE Therapeutics	NASDAQ:DICE	DICE Therapeutics Inc
08/08/2023	4:01PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DICE	DICE Therapeutics Inc
07/25/2023	7:11AM	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
07/25/2023	6:55AM	PR Newswire (US)	Lilly Announces Extension of Tender Offer to Acquire DICE	NASDAQ:DICE	DICE Therapeutics Inc
07/17/2023	5:23PM	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
06/30/2023	4:22PM	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:DICE	DICE Therapeutics Inc
06/23/2023	5:37PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DICE	DICE Therapeutics Inc
06/23/2023	5:11PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
06/22/2023	4:33PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
06/21/2023	5:01PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
06/20/2023	4:07PM	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DICE	DICE Therapeutics Inc
06/20/2023	10:15AM	Dow Jones News	Trending: Eli Lilly Buys DICE Therapeutics in Deal Worth $2.4 Billion	NASDAQ:DICE	DICE Therapeutics Inc
06/20/2023	8:21AM	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:DICE	DICE Therapeutics Inc
06/20/2023	7:42AM	Dow Jones News	Eli Lilly to Acquire DICE Therapeutics for $2.4 Billion	NASDAQ:DICE	DICE Therapeutics Inc
06/20/2023	7:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DICE	DICE Therapeutics Inc